Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: BISPHOSPHONATE, . Treffer: 66

2023

Beltran-Bless, AA; Clemons, MJ; Fesl, C; Greil, R; Pond, GR; Balic, M; Vandermeer, L; Bjelic-Radisic, V; Singer, CF; Steger, GG; Helfgott, R; Egle, D; Solkner, L; Gampenrieder, SP; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Rinnerthaler, G; Pfeiler, G; Fohler, H; Hlauschek, D; Hilton, J; Gnant, M Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
EUR J CANCER. 2023; 180: 108-116. Doi: 10.1016/j.ejca.2022.12.003
Web of Science PubMed FullText FullText_MUG

 

2022

Dimai, HP; Fahrleitner-Pammer, A Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions.
Best Pract Res Clin Rheumatol. 2022; 101780 Doi: 10.1016/j.berh.2022.101780
Web of Science PubMed FullText FullText_MUG

 

Kammerhofer, G; Somogyi, KS; Biczó, Z; Végh, D; Ujpál, M; Vaszilkó, MT; Bányai, D; Füzes, A; Végh, Á; Joób-Fancsaly, Á; Németh, Z A gyógyszer okozta állcsontnekrózis és a vércukorszint kapcsolata.
Orv Hetil. 2022; 163(15):599-605 Doi: 10.1556/650.2022.32445
Web of Science PubMed FullText FullText_MUG

 

2021

Tsourdi, E; Zillikens, MC; Meier, C; Body, JJ; Gonzalez, Rodriguez, E; Anastasilakis, AD; Abrahamsen, B; McCloskey, E; Hofbauer, LC; Guañabens, N; Obermayer-Pietsch, B; Ralston, SH; Eastell, R; Pepe, J; Palermo, A; Langdahl, B Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
J Clin Endocrinol Metab. 2020; Doi: 10.1210/clinem/dgaa756
Web of Science PubMed FullText FullText_MUG

 

2020

Alonso, N; Larraz-Prieto, B; Berg, K; Lambert, Z; Redmond, P; Harris, SE; Deary, IJ; Pugh, C; Prendergast, J; Ralston, SH Loss-of-Function Mutations in the ALPL Gene Presenting with Adult Onset Osteoporosis and Low Serum Concentrations of Total Alkaline Phosphatase.
J Bone Miner Res. 2020; 35(4):657-661 Doi: 10.1002/jbmr.3928 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Body, JJ; Marin, F; Kendler, DL; Zerbini, CAF; López-Romero, P; Möricke, R; Casado, E; Fahrleitner-Pammer, A; Stepan, JJ; Lespessailles, E; Minisola, S; Geusens, P Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial.
Osteoporos Int. 2020; 31(10):1935-1942 Doi: 10.1007/s00198-020-05463-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Geusens, P; Kendler, DL; Fahrleitner-Pammer, A; López-Romero, P; Marin, F Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical Trial.
Calcif Tissue Int. 2020; 106(6):646-654 Doi: 10.1007/s00223-020-00683-6 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Pepe, J; Body, JJ; Hadji, P; McCloskey, E; Meier, C; Obermayer-Pietsch, B; Palermo, A; Tsourdi, E; Zillikens, MC; Langdahl, B; Ferrari, S Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOF.
J Clin Endocrinol Metab. 2020; 105(8): Doi: 10.1210/clinem/dgaa306 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schneider, KN; Masthoff, M; Gosheger, G; Klingebiel, S; Schorn, D; Röder, J; Vogler, T; Wildgruber, M; Andreou, D Gorham-Stout disease: good results of bisphosphonate treatment in 6 of 7 patients.
Acta Orthop. 2020; 91(2):209-214 Doi: 10.1080/17453674.2019.1709716 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Balic, M; Thomssen, C; Würstlein, R; Gnant, M; Harbeck, N St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.
Breast Care (Basel). 2019; 14(2):103-110 Doi: 10.1159/000499931 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lorentzon, M; Branco, J; Brandi, ML; Bruyère, O; Chapurlat, R; Cooper, C; Cortet, B; Diez-Perez, A; Ferrari, S; Gasparik, A; Herrmann, M; Jorgensen, NR; Kanis, J; Kaufman, JM; Laslop, A; Locquet, M; Matijevic, R; McCloskey, E; Minisola, S; Pikner, R; Reginster, JY; Rizzoli, R; Szulc, P; Vlaskovska, M; Cavalier, E Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
Adv Ther. 2019; 36(10):2811-2824 Doi: 10.1007/s12325-019-01063-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Minisola, S; Marin, F; Kendler, DL; Geusens, P; Zerbini, CAF; Russo, LA; Casado, E; Fahrleitner-Pammer, A; Stepan, JJ; Lespessailles, E; Moericke, R; Bagur, A; Lakatos, P; López-Romero, P; Body, JJ Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.
Arch Osteoporos. 2019; 14(1):10-10 Doi: 10.1007/s11657-019-0561-x
Web of Science PubMed FullText FullText_MUG

 

Skrabl-Baumgartner, A; Singer, P; Greimel, T; Gorkiewicz, G; Hermann, J Chronic non-bacterial osteomyelitis: a comparative study between children and adults.
Pediatr Rheumatol Online J. 2019; 17(1):49-49 Doi: 10.1186/s12969-019-0353-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Vom Scheidt, A; Hemmatian, H; Püschel, K; Krause, M; Amling, M; Busse, B Bisphosphonate treatment changes regional distribution of trabecular microstructure in human lumbar vertebrae.
Bone. 2019; 127(1): 482-487. Doi: 10.1016/j.bone.2019.07.003
Web of Science PubMed FullText FullText_MUG

 

2018

Geusens, P; Marin, F; Kendler, DL; Russo, LA; Zerbini, CA; Minisola, S; Body, JJ; Lespessailles, E; Greenspan, SL; Bagur, A; Stepan, JJ; Lakatos, P; Casado, E; Moericke, R; López-Romero, P; Fahrleitner-Pammer, A Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.
J Bone Miner Res. 2018; 33(5):783-794 Doi: 10.1002/jbmr.3384 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jung, RE; Al-Nawas, B; Araujo, M; Avila-Ortiz, G; Barter, S; Brodala, N; Chappuis, V; Chen, B; De Souza, A; Almeida, RF; Fickl, S; Finelle, G; Ganeles, J; Gholami, H; Hammerle, C; Jensen, S; Jokstad, A; Katsuyama, H; Kleinheinz, J; Kunavisarut, C; Mardas, N; Monje, A; Papaspyridakos, P; Payer, M; Schiegnitz, E; Smeets, R; Stefanini, M; Ten Bruggenkate, C; Vazouras, K; Weber, HP; Weingart, D; Windisch, P Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes.
Clin Oral Implants Res. 2018; 29 Suppl 16(466):69-77 Doi: 10.1111/clr.13342 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Milovanovic, P; Vom Scheidt, A; Mletzko, K; Sarau, G; Püschel, K; Djuric, M; Amling, M; Christiansen, S; Busse, B Bone tissue aging affects mineralization of cement lines.
Bone. 2018; 110(1): 187-193. Doi: 10.1016/j.bone.2018.02.004
Web of Science PubMed FullText FullText_MUG

 

2017

Diez-Perez, A; Naylor, KE; Abrahamsen, B; Agnusdei, D; Brandi, ML; Cooper, C; Dennison, E; Eriksen, EF; Gold, DT; Guañabens, N; Hadji, P; Hiligsmann, M; Horne, R; Josse, R; Kanis, JA; Obermayer-Pietsch, B; Prieto-Alhambra, D; Reginster, JY; Rizzoli, R; Silverman, S; Zillikens, MC; Eastell, R; Adherence Working Group of the International Osteoporosis Foundation and the European Calcified Tissue Society International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.
Osteoporos Int. 2017; 28(3):767-774 Doi: 10.1007/s00198-017-3906-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fung, P; Bedogni, G; Bedogni, A; Petrie, A; Porter, S; Campisi, G; Bagan, J; Fusco, V; Saia, G; Acham, S; Musto, P; Petrucci, MT; Diz, P; Colella, G; Mignogna, MD; Pentenero, M; Arduino, P; Lodi, G; Maiorana, C; Manfredi, M; Hallberg, P; Wadelius, M; Takaoka, K; Leung, YY; Bonacina, R; Schiødt, M; Lakatos, P; Taylor, T; De Riu, G; Favini, G; Rogers, SN; Pirmohamed, M; Nicoletti, P; GENVABO Consortium; Fedele, S Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.
Oral Dis. 2017; 23(4):477-483 Doi: 10.1111/odi.12632 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Suppan, C; Balic, M Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016.
Memo. 2017; 10(2):82-85 Doi: 10.1007/s12254-017-0328-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tsourdi, E; Langdahl, B; Cohen-Solal, M; Aubry-Rozier, B; Eriksen, EF; Guañabens, N; Obermayer-Pietsch, B; Ralston, SH; Eastell, R; Zillikens, MC Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.
Bone. 2017; 105(21-22):11-17 Doi: 10.1016/j.bone.2017.08.003
Web of Science PubMed FullText FullText_MUG

 

2016

Brozek, W; Reichardt, B; Zwerina, J; Dimai, HP; Klaushofer, K; Zwettler, E Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study.
Osteoporos Int. 2016; 27(1):387-396 Doi: 10.1007/s00198-015-3415-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Khan, AA; Morrison, A; Kendler, DL; Rizzoli, R; Hanley, DA; Felsenberg, D; McCauley, LK; O'Ryan, F; Reid, IR; Ruggiero, SL; Taguchi, A; Tetradis, S; Watts, NB; Brandi, ML; Peters, E; Guise, T; Eastell, R; Cheung, AM; Morin, SN; Masri, B; Cooper, C; Morgan, SL; Obermayer-Pietsch, B; Langdahl, BL; Dabagh, RA; Davison, KS; Sándor, GK; Josse, RG; Bhandari, M; El Rabbany, M; Pierroz, DD; Sulimani, R; Saunders, DP; Brown, JP; Compston, J; International Task Force on Osteonecrosis of the Jaw Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.
J Clin Densitom. 2016; 20(1):8-24 Doi: 10.1016/j.jocd.2016.09.005
Web of Science PubMed FullText FullText_MUG

 

Svejda, B; Muschitz, Ch; Gruber, R; Brandtner, Ch; Svejda, Ch; Gasser, RW; Santler, G; Dimai, HP [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Wien Med Wochenschr. 2016; 166(1-2):68-74 Doi: 10.1007/s10354-016-0437-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Assaf, AT; Zrnc, TA; Remus, CC; Adam, G; Zustin, J; Heiland, M; Friedrich, RE; Derlin, T Intraindividual comparison of preoperative (99m)Tc-MDP SPECT/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw.
J Craniomaxillofac Surg. 2015; 43(8):1461-1469 Doi: 10.1016/j.jcms.2015.06.025
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Mlineritsch, B; Stoeger, H; Luschin-Ebengreuth, G; Knauer, M; Moik, M; Jakesz, R; Seifert, M; Taucher, S; Bjelic-Radisic, V; Balic, M; Eidtmann, H; Eiermann, W; Steger, G; Kwasny, W; Dubsky, P; Selim, U; Fitzal, F; Hochreiner, G; Wette, V; Sevelda, P; Ploner, F; Bartsch, R; Fesl, C; Greil, R; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Ann Oncol. 2015; 26(2):313-320 Doi: 10.1093/annonc/mdu544 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Pfeiler, G; Dubsky, PC; Hubalek, M; Greil, R; Jakesz, R; Wette, V; Balic, M; Haslbauer, F; Melbinger, E; Bjelic-Radisic, V; Artner-Matuschek, S; Fitzal, F; Marth, C; Sevelda, P; Mlineritsch, B; Steger, GG; Manfreda, D; Exner, R; Egle, D; Bergh, J; Kainberger, F; Talbot, S; Warner, D; Fesl, C; Singer, CF; Austrian Breast and Colorectal Cancer Study Group Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
LANCET. 2015; 386(9992): 433-443. Doi: 10.1016/S0140-6736(15)60995-3
Web of Science PubMed FullText FullText_MUG

 

Khan, AA; Morrison, A; Hanley, DA; Felsenberg, D; McCauley, LK; O'Ryan, F; Reid, IR; Ruggiero, SL; Taguchi, A; Tetradis, S; Watts, NB; Brandi, ML; Peters, E; Guise, T; Eastell, R; Cheung, AM; Morin, SN; Masri, B; Cooper, C; Morgan, SL; Obermayer-Pietsch, B; Langdahl, BL; Al Dabagh, R; Davison, KS; Kendler, DL; Sándor, GK; Josse, RG; Bhandari, M; El Rabbany, M; Pierroz, DD; Sulimani, R; Saunders, DP; Brown, JP; Compston, J; International Task Force on Osteonecrosis of the Jaw Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
J Bone Miner Res. 2015; 30(1): 3-23. Doi: 10.1002/jbmr.2405 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Assaf, AT; Jürgens, TP; Benecke, AW; Riecke, B; Blessmann, M; Zrnc, TA; Much, CC; Heiland, M; Friedrich, RE Numb chin syndrome: a rare and often overlooked symptom.
J Oral Facial Pain Headache. 2014; 28(1): 80-90. Doi: 10.11607/jop.994 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Assaf, AT; Zrnc, TA; Riecke, B; Wikner, J; Zustin, J; Friedrich, RE; Heiland, M; Smeets, R; Gröbe, A Intraoperative efficiency of fluorescence imaging by Visually Enhanced Lesion Scope (VELscope) in patients with bisphosphonate related osteonecrosis of the jaw (BRONJ).
J Craniomaxillofac Surg. 2014; 42(5): e157-e164. Doi: 10.1016/j.jcms.2013.07.014
Web of Science PubMed FullText FullText_MUG

 

Jacobsen, C; Zemann, W; Obwegeser, JA; Grätz, KW; Metzler, P The phosphorous necrosis of the jaws and what can we learn from the past: a comparison of "phossy" and "bisphossy" jaw.
Oral Maxillofac Surg. 2014; 18(1):31-37 Doi: 10.1007/s10006-012-0376-z
PubMed FullText FullText_MUG

 

Kerschan-Schindl, K; Mikosch, P; Obermayer-Pietsch, B; Gasser, RW; Dimai, HP; Fahrleitner-Pammer, A; Dobnig, H; Roschger, P; Preisinger, E; Klaushofer, K; Resch, H; Pietschmann, P Current controversies in clinical management of postmenopausal osteoporosis.
Exp Clin Endocrinol Diabetes. 2014; 122(8):437-444 Doi: 10.1055/s-0034-1374610
Web of Science PubMed FullText FullText_MUG

 

Rordorf, T; Hassan, AA; Azim, H; Alexandru, E; Er, O; Gokmen, E; Güral, Z; Mardiak, J; Minchev, V; Peintinger, F; Szendroi, M; Takac, I; Tesarova, P; Vorobiof, D; Vrbanec, D; Yildiz, R; Yücel, S; Zekri, J; Oyan, B; Central European Cooperative Oncology Group (CECOG); Swiss Group for Clinical Cancer Research (SAKK) Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup.
Breast. 2014; 23(5):511-525 Doi: 10.1016/j.breast.2014.05.023 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rugani, P; Luschin, G; Jakse, N; Kirnbauer, B; Lang, U; Acham, S Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer.
Clin Oral Investig. 2014; 18(2):401-407 Doi: 10.1007/s00784-013-1012-5
Web of Science PubMed FullText FullText_MUG

 

Zustin, J; Reske, D; Zrnc, TA; Heiland, M; Scheuer, HA; Assaf, AT; Friedrich, RE Pseudoepitheliomatous hyperplasia associated with bisphosphonate-related osteonecrosis of the jaw.
In Vivo. 2014; 28(1): 125-131.
Web of Science PubMed

 

2013

Jacobsen, C; Metzler, P; Rössle, M; Obwegeser, J; Zemann, W; Grätz, KW Osteopathology induced by bisphosphonates and dental implants: clinical observations.
Clin Oral Investig. 2013; 17(1):167-175 Doi: 10.1007/s00784-012-0708-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kerschan-Schindl, K; Haschka, J; Obermayer-Pietsch, B; Gasser, RW; Dimai, HP; Fahrleitner-Pammer, A; Dobnig, H; Roschger, P; Preisinger, E; Klaushofer, K; Resch, H; Pietschmann, P How long should women with postmenopausal osteoporosis be treated with a bisphosphonate?
Horm Metab Res. 2013; 45(9):621-628 Doi: 10.1055/s-0033-1345207
Web of Science PubMed FullText FullText_MUG

 

Lechleitner, M; Pils, K; Roller-Wirnsberger, R; Beubler, E; Gasser, R; Mrak, P; Hoppichler, F; Pietschmann, P Diabetes and osteoporosis: pathophysiological interactions and clinical importance for geriatric patients].
Z GERONTOL GERIATRIE. 2013; 46(5): 390-397. Doi: 10.1007/s00391-013-0518-4
Web of Science PubMed FullText FullText_MUG

 

Lionetto, S; Little, A; Moriceau, G; Heymann, D; Decurtins, M; Plecko, M; Filgueira, L; Cadosch, D Pharmacological blocking of the osteoclastic biocorrosion of surgical stainless steel in vitro.
J Biomed Mater Res A. 2013; 101(4): 991-997. Doi: 10.1002/jbm.a.34402
Web of Science PubMed FullText FullText_MUG

 

2012

Gnant, M; Balic, M; Petru, E; Raunik, W; Singer, CF; Steger, GG; Watzke, IM; Brodowicz, T Treatment of Bone Metastases in Patients with Advanced Breast Cancer.
Breast Care (Basel). 2012; 7(2):92-98 Doi: 10.1159/000338650 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Jakob, F; Oertel, H; Langdahl, B; Ljunggren, O; Barrett, A; Karras, D; Walsh, JB; Fahrleitner-Pammer, A; Rajzbaum, G; Barker, C; Lems, WF; Marin, F Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study.
Eur J Endocrinol. 2012; 166(1):87-97 Doi: 10.1530/EJE-11-0740 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kühl, S; Walter, C; Acham, S; Pfeffer, R; Lambrecht, JT Bisphosphonate-related osteonecrosis of the jaws--a review.
Oral Oncol. 2012; 48(10):938-947 Doi: 10.1016/j.oraloncology.2012.03.028
Web of Science PubMed FullText FullText_MUG

 

Muschitz, C; Fahrleitner-Pammer, A; Huber, J; Preisinger, E; Kudlacek, S; Resch, H Update on denosumab in postmenopausal osteoporosis--recent clinical data.
Wien Med Wochenschr. 2012; 162(17-18):374-379 Doi: 10.1007/s10354-012-0116-x
PubMed FullText FullText_MUG

 

Pabinger, C; Heu, C; Frohner, A; Dimai, HP Pregnancy- and lactation-associated transient osteoporosis of both hips in a 32 year old patient with osteogenesis imperfecta
BONE. 2012; 51(1): 142-144. Doi: 10.1016/j.bone.2012.04.013 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2011

Hautmann, AH; Elad, S; Lawitschka, A; Greinix, H; Bertz, H; Halter, J; Faraci, M; Hofbauer, LC; Lee, S; Wolff, D; Holler, E Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Transpl Int. 2011; 24(9):867-879 Doi: 10.1111/j.1432-2277.2011.01264.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Reiter, N; El-Shabrawi, L; Leinweber, B; Berghold, A; Aberer, E Calcinosis cutis Part II. Treatment options.
J AM ACAD DERMATOL. 2011; 65(1): 15-22. Doi: 10.1016/j.jaad.2010.08.039
Web of Science PubMed FullText FullText_MUG

 

2010

Rugani, P; Acham, S; Truschnegg, A; Obermayer-Pietsch, B; Jakse, N Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110(6):e1-e6 Doi: 10.1016/j.tripleo.2010.08.013 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Visconti, MR; Langston, AL; Alonso, N; Goodman, K; Selby, PL; Fraser, WD; Ralston, SH Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone.
J Bone Miner Res. 2010; 25(11): 2368-73. Doi: 10.1002/jbmr.132
Web of Science PubMed FullText FullText_MUG

 

2009

Dimai, HP; Pietschmann, P; Resch, H; Preisinger, E; Fahrleitner-Pammer, A; Dobnig, H; Klaushofer, K; Austrian Society for Bone and Mineral Research (AuSBMR) Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women--update 2009
Wien Med Wochenschr Suppl. 2009; (122): 1-34. Doi: 10.1007/s10354-009-0656-x
PubMed FullText FullText_MUG Google Scholar

 

Dobnig, H; Stepan, JJ; Burr, DB; Li, J; Michalská, D; Sipos, A; Petto, H; Fahrleitner-Pammer, A; Pavo, I Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate *
J Bone Miner Res. 2009; 24(12): 1998-2006. Doi: 10.1359/jbmr.090527 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum